MART-1 nonamer antigen

The MART-1 nonamer peptide (LAGIGILTV) is a melanoma-associated antigen recognized by cytotoxic T cells. It acts as a superagonist to enhance T-cell responses ex vivo and serves as a critical model for developing antitumor vaccines, with applications in both in vitro T-cell stimulation and in vivo immunization studies.